Cargando…

Modular Proteoglycan Perlecan/HSPG2: Mutations, Phenotypes, and Functions

Heparan sulfate proteoglycan 2 (HSPG2) is an essential, highly conserved gene whose expression influences many developmental processes including the formation of the heart and brain. The gene is widely expressed throughout the musculoskeletal system including cartilage, bone marrow and skeletal musc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martinez, Jerahme R., Dhawan, Akash, Farach-Carson, Mary C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266596/ https://www.ncbi.nlm.nih.gov/pubmed/30453502 http://dx.doi.org/10.3390/genes9110556

Ejemplares similares

Evolution of the Perlecan/HSPG2 Gene and Its Activation in Regenerating Nematostella vectensis
por: Warren, Curtis R., et al.
Publicado: (2015)

Matrilysin/MMP-7 Cleavage of Perlecan/HSPG2 Complexed with Semaphorin 3A Supports FAK-Mediated Stromal Invasion by Prostate Cancer Cells
por: Grindel, Brian J., et al.
Publicado: (2018)

Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients
por: Grindel, Brian, et al.
Publicado: (2016)

Expression of the Heparan Sulfate Proteoglycan, Perlecan, during Mouse Embryogenesis and Perlecan Chondrogenic Activity In Vitro
por: French, M.M., et al.
Publicado: (1999)

Correction: Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients
por: Grindel, Brian, et al.
Publicado: (2016)

Perlecan/Hspg2 Deficiency Alters the Pericellular Space of the Lacunocanalicular System Surrounding Osteocytic Processes in Cortical Bone
por: Thompson, William R, et al.
Publicado: (2011)

Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer
por: Kalscheuer, Stephen, et al.
Publicado: (2019)

Trabecular Bone Deficit and Enhanced Anabolic Response to Re-Ambulation after Disuse in Perlecan-Deficient Skeleton
por: Parajuli, Ashutosh, et al.
Publicado: (2020)

What Are the Potential Roles of Nuclear Perlecan and Other Heparan Sulphate Proteoglycans in the Normal and Malignant Phenotype
por: Hayes, Anthony J., et al.
Publicado: (2021)

Perlecan domain 1 recombinant proteoglycan augments BMP-2 activity and osteogenesis
por: DeCarlo, Arthur A, et al.
Publicado: (2012)

Cancer Metastasis: The Role of the Extracellular Matrix and the Heparan Sulfate Proteoglycan Perlecan
por: Elgundi, Zehra, et al.
Publicado: (2020)

The Association between Genes Polymorphisms of Heparan Sulfate Proteoglycan 2 (HSPG2) and Chondroitin Sulfate Proteoglycan 2 (CSPG2) and Intracranial Aneurysm Susceptibility: A Meta-Analysis
por: LIU, Huahui, et al.
Publicado: (2019)

Sustained delivery of recombinant human bone morphogenetic protein-2 from perlecan domain I - functionalized electrospun poly (ε-caprolactone) scaffolds for bone regeneration
por: Chiu, Yu-Chieh, et al.
Publicado: (2016)

Regulation of Glycoprotein VI-Dependent Platelet Activation and Thrombus Formation by Heparan Sulfate Proteoglycan Perlecan
por: Provenzale, Isabella, et al.
Publicado: (2023)

A Novel Pathogenic HSPG2 Mutation in Schwartz–Jampel Syndrome
por: Lin, Po-Yu, et al.
Publicado: (2021)

Peroxynitrite modifies the structure and function of the extracellular matrix proteoglycan perlecan by reaction with both the protein core and the heparan sulfate chains
por: Kennett, Eleanor C., et al.
Publicado: (2010)

SULF1 suppresses Wnt3A-driven growth of bone metastatic prostate cancer in perlecan-modified 3D cancer-stroma-macrophage triculture models
por: Brasil da Costa, Fabio Henrique, et al.
Publicado: (2020)

Cleavage of the Perlecan-Semaphorin 3A-Plexin A1-Neuropilin-1 (PSPN) Complex by Matrix Metalloproteinase 7/Matrilysin Triggers Prostate Cancer Cell Dyscohesion and Migration
por: Tellman, Tristen V., et al.
Publicado: (2021)

Perlecan, a heparan sulfate proteoglycan, regulates systemic metabolism with dynamic changes in adipose tissue and skeletal muscle
por: Yamashita, Yuri, et al.
Publicado: (2018)

An immunohistochemical study of basement membrane heparan sulfate proteoglycan (perlecan) in oral epithelial dysplasia and squamous cell carcinoma
por: Mishra, Mithilesh, et al.
Publicado: (2013)

Is HSPG2 a modifier gene for Marfan syndrome?
por: Gerdes Gyuricza, Isabela, et al.
Publicado: (2020)

Perlecan, A Multi-Functional, Cell-Instructive, Matrix-Stabilizing Proteoglycan With Roles in Tissue Development Has Relevance to Connective Tissue Repair and Regeneration
por: Hayes, Anthony J., et al.
Publicado: (2022)

Perlecan in the Natural and Cell Therapy Repair of Human Adult Articular Cartilage: Can Modifications in This Proteoglycan Be a Novel Therapeutic Approach?
por: Garcia, John, et al.
Publicado: (2021)

Perlecan, a candidate gene for the CAPB locus, regulates prostate cancer cell growth via the Sonic Hedgehog pathway
por: Datta, Milton W, et al.
Publicado: (2006)

Life without Perlecan Has Its Problems
por: Olsen, Bjorn R.
Publicado: (1999)

The HSPG syndecan is a core organizer of cholinergic synapses
por: Zhou, Xin, et al.
Publicado: (2021)

Gabapentin Disrupts Binding of Perlecan to the α(2)δ(1) Voltage Sensitive Calcium Channel Subunit and Impairs Skeletal Mechanosensation
por: Reyes Fernandez, Perla C., et al.
Publicado: (2022)

HSPG2 Mutation Association with Immune Checkpoint Inhibitor Outcome in Melanoma and Non-Small Cell Lung Cancer
por: Zhang, Wenjing, et al.
Publicado: (2022)

HSPG-Deficient Zebrafish Uncovers Dental Aspect of Multiple Osteochondromas
por: Wiweger, Malgorzata I., et al.
Publicado: (2012)

Perlecan controls neurogenesis in the developing telencephalon
por: Girós, Amparo, et al.
Publicado: (2007)

Review of Alterations in Perlecan-Associated Vascular Risk Factors in Dementia
por: Trout, Amanda L., et al.
Publicado: (2020)

Investigation of the HSPG2 Gene in Tardive Dyskinesia – New Data and Meta-Analysis
por: Zai, Clement C., et al.
Publicado: (2018)

Osteocytic Pericellular Matrix (PCM): Accelerated Degradation under In Vivo Loading and Unloading Conditions Using a Novel Imaging Approach
por: Pei, Shaopeng, et al.
Publicado: (2021)

A central function for perlecan in skeletal muscle and cardiovascular development
por: Zoeller, Jason J., et al.
Publicado: (2008)

Novel HSPG2 Gene Mutation Causing Schwartz–Jampel Syndrome in a Moroccan Family: A Literature Review
por: Brugnoni, Raffaella, et al.
Publicado: (2023)

Perlecan and the Blood-Brain Barrier: Beneficial Proteolysis?
por: Roberts, Jill, et al.
Publicado: (2012)

Perlecan and synaptophysin changes in denervated skeletal muscle☆
por: Ma, Kai, et al.
Publicado: (2012)

Increased Risk of Aortic Dissection with Perlecan Deficiency
por: Nonaka, Risa, et al.
Publicado: (2021)

HSPG2 overexpression independently predicts poor survival in patients with acute myeloid leukemia
por: Zhou, Xiaojia, et al.
Publicado: (2020)

Similarity of Recombinant Human Perlecan Domain 1 by Alternative Expression Systems Bioactive Heterogenous Recombinant Human Perlecan D1
por: Ellis, April L, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_r1khjjradgurcnhdupe9dfvndb